Clinical value of antistaphylococcal drugs.
D000208:Acute Disease; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use; D002908:Chronic Disease; D003604:Czechoslovakia; D004341:Drug Evaluation; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004917:Erythromycin / Q000627:therapeutic use; D005672:Fusidic Acid / Q000627:therapeutic use; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use; D009675:Novobiocin / Q000627:therapeutic use; D010019:Osteomyelitis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D012008:Recurrence; D012294:Rifamycins / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
D000890:Anti-Infective Agents; D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D012294:Rifamycins; D009675:Novobiocin; D005672:Fusidic Acid; D004917:Erythromycin; D014640:Vancomycin; D014295:Trimethoprim; D008034:Lincomycin; D013420:Sulfamethoxazole